Literature DB >> 29097794

Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners.

K Staines1, H Rogers1.   

Abstract

Objectives To provide an overview of the current thinking in terms of the diagnosis and management of oral leukoplakia and proliferative verrucous leukoplakia as relevant to general dental practitioners.Data sources, data selection, data extraction, data synthesis We searched the MEDLINE Ovid, EMBASE databases and the Cochrane Library, (1990 to 16 April 2017), restricting our search to English language with the following key words: leukoplakia, white patch, proliferative verrucous leukoplakia, precancerous lesion, premalignant lesions, potentially malignant oral conditions and potentially malignant oral disorders. The two authors selected key papers and engaged in collaborative data extraction and synthesis of the selected reference material.Conclusions General dental practitioners (GDPs) are likely to encounter patients with a known or yet undiagnosed oral leukoplakia in their clinical practice. The diagnosis is clinically based as there are no pathognomonic histopathological features. The definition of leukoplakia has evolved over the years. The importance of recognition and appropriate management relating to this condition is described particularly as it is one of the oral potentially malignant lesions. The inferred increased risk of malignant transformation is well documented however controversy still persists in terms of the appropriate management for these lesions. Proliferative verrucous leukoplakia is a recalcitrant, often widespread and multifocal distinct type of leukoplakia. It is considered to have a high rate of malignant transformation with implications in terms of lifelong monitoring both clinically and histopathologically. A high index of suspicion is important for general dental practitioners in order to identify such lesions that would require onward referral for further investigation and management.

Entities:  

Mesh:

Year:  2017        PMID: 29097794     DOI: 10.1038/sj.bdj.2017.881

Source DB:  PubMed          Journal:  Br Dent J        ISSN: 0007-0610            Impact factor:   1.626


  56 in total

Review 1.  Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management.

Authors:  Isaäc van der Waal
Journal:  Oral Oncol       Date:  2010-03-21       Impact factor: 5.337

2.  The clinical determinants of malignant transformation in oral epithelial dysplasia.

Authors:  M W Ho; J M Risk; J A Woolgar; E A Field; J K Field; J C Steele; B P Rajlawat; A Triantafyllou; S N Rogers; D Lowe; R J Shaw
Journal:  Oral Oncol       Date:  2012-05-10       Impact factor: 5.337

3.  High incidence of DNA ploidy abnormalities and increased Mcm2 expression may predict malignant change in oral proliferative verrucous leukoplakia.

Authors:  Adriele F Gouvêa; Alan R Santos Silva; Paul M Speight; Keith Hunter; Román Carlos; Pablo A Vargas; Oslei P de Almeida; Márcio A Lopes
Journal:  Histopathology       Date:  2013-01-24       Impact factor: 5.087

Review 4.  Interventions for treating oral leukoplakia to prevent oral cancer.

Authors:  Giovanni Lodi; Roberto Franchini; Saman Warnakulasuriya; Elena Maria Varoni; Andrea Sardella; Alexander R Kerr; Antonio Carrassi; L C I MacDonald; Helen V Worthington
Journal:  Cochrane Database Syst Rev       Date:  2016-07-29

5.  Candida in oral pre-cancer and oral cancer.

Authors:  P R Sanjaya; S Gokul; B Gururaj Patil; Ramanjeneya Raju
Journal:  Med Hypotheses       Date:  2011-10-05       Impact factor: 1.538

6.  Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up.

Authors:  Paolo G Arduino; Antonio Surace; Mario Carbone; Alessandra Elia; Gianluca Massolini; Sergio Gandolfo; Roberto Broccoletti
Journal:  J Oral Pathol Med       Date:  2009-05-18       Impact factor: 4.253

Review 7.  Pooled estimate of world leukoplakia prevalence: a systematic review.

Authors:  Stefano Petti
Journal:  Oral Oncol       Date:  2003-12       Impact factor: 5.337

8.  Proliferative verrucous vs conventional leukoplakia: no significantly increased risk of HPV infection.

Authors:  G Campisi; L Giovannelli; P Ammatuna; G Capra; G Colella; C Di Liberto; S Gandolfo; M Pentenero; M Carrozzo; R Serpico; M D'Angelo
Journal:  Oral Oncol       Date:  2004-09       Impact factor: 5.337

Review 9.  Diagnostic aids in the screening of oral cancer.

Authors:  Stefano Fedele
Journal:  Head Neck Oncol       Date:  2009-01-30

10.  Proliferative verrucous leukoplakia; a critical appraisal of the diagnostic criteria.

Authors:  Vinicius C Carrard; Elisabeth R E A Brouns; Isaäc van der Waal
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-05-01
View more
  3 in total

1.  Characteristics and trends of oral leukoplakia research: A bibliometric study of the 100 most cited articles.

Authors:  Wei Liu; Yu Zhang; Lan Wu; Xi Yang; Linjun Shi
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 2.  Oral Potentially Malignant Disorders: Etiology, Pathogenesis, and Transformation Into Oral Cancer.

Authors:  Pratima Kumari; Priyanka Debta; Anshuman Dixit
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

3.  Improvement in the risk assessment of oral leukoplakia through morphology-related copy number analysis.

Authors:  Xiaotian Li; Lu Liu; Jianyun Zhang; Ming Ma; Lisha Sun; Xuefen Li; Heyu Zhang; Jianbin Wang; Yanyi Huang; Tiejun Li
Journal:  Sci China Life Sci       Date:  2021-08-02       Impact factor: 6.038

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.